Tauriga Secures Investment Of $80,000 USD Through A 5% Promissory Note With Fixed Conversion Price Of $0.00125 Per Share Post author:Sam Post published:June 29, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Medidata Solutions, Inc. Successfully Hosts Annual Conference Series July 12, 2017 AbbVie Presents New Phase 2b Data on Upadacitinib in Atopic Dermatitis February 18, 2018 Innovus Pharma Announces The Launch Of Zestra In France, Belgium And Monaco By Its Partner, September 18, 2017
Innovus Pharma Announces The Launch Of Zestra In France, Belgium And Monaco By Its Partner, September 18, 2017